Hyperinsulinemia resulting from systemic insulin resistance causes insulin resistance in central neurons (59), which in turn may exacerbate ischemic cerebrovascular damage by downregulating the PI3K-AKT signaling pathway and inhibiting cell survival. The gene discussed is AKT1; the disease is Hyperinsulinemia.